Margaret Ann Snowden

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michèle Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet · 2013 · 1K citations · Full text

Vaccination, Vaccine Safety, Vaccinology +10

T-cell activation is an immune correlate of risk in BCG vaccinated infants

Helen A. Fletcher, Margaret Ann Snowden, Bernard Landry et al. · Nature Communications · 2016 · 268 citations · Full text

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Angelique Kany Kany Luabeya, Benjamin M. Kagina, Michèle Tameris et al. · Vaccine · 2015 · 190 citations

Vaccination, Pulmonary Tuberculosis, Tuberculosis Prevention +11

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

Rhea N. Coler, Tracey A. Day, Ruth D. Ellis et al. · npj Vaccines · 2018 · 158 citations · Full text

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants

Julius Müller, Rachel Tanner, Magali Matsumiya et al. · JCI Insight · 2019 · 60 citations · Full text